Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2021-05-26 2019-04-26
Drug Identification Number 02370611 02370611
Brand name ACT DILTIAZEM CD ACT DILTIAZEM CD
Common or Proper name DILTIAZEM CD DILTIAZEM CD
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 120MG 120MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-01 2019-04-01
Estimated end date Unknown Unknown
Actual end date 2021-05-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments ACT Item is discontinued, TEVA DIN is now available.
Health Canada comments